Kazuhiko Yamamoto
Director/Board Member at Bio Palette Co., Ltd.
Profile
Kazuhiko Yamamoto is currently a Director at Bio Palette Co., Ltd.
and Synplogen Co., Ltd.
He obtained an undergraduate degree from the University of Hitotsubashi in 1988.
Kazuhiko Yamamoto active positions
| Companies | Position | Start |
|---|---|---|
Bio Palette Co., Ltd.
 Bio Palette Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan. | Director/Board Member | 01/02/2019 |
Synplogen Co., Ltd.
 Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Director/Board Member | 01/09/2018 |
Training of Kazuhiko Yamamoto
| University of Hitotsubashi | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Bio Palette Co., Ltd.
Bio Palette Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan. | Commercial Services |
Synplogen Co., Ltd.
Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Commercial Services |
- Stock Market
- Insiders
- Kazuhiko Yamamoto
